文献速递主动脉疾病

腹主动脉瘤十年单中心结果:EVAR与开放修复比较

Ten-Year Single-Center Results of Abdominal Aortic Aneurysm Treatment: Endovascular versus Open Repair.
PubMed 文献 · Ann Vasc Surg · 2017-05-22

该单中心回顾性研究将1998至2006年择期修复的肾下腹主动脉瘤患者按年龄、性别、肾病、吸烟、高血压、慢阻肺和冠心病匹配,比较EVAR与开放修复的远期生存。两组各108例,围术期死亡仅开放组1例(P=0.316),累积生存无差异(P=0.458),但EVAR再干预率显著更高(16.7% vs 6.5%,P=0.018)。

要点

  • 匹配后EVAR与开放修复的远期累积生存无显著差异(P=0.458)。
  • EVAR组再干预率显著高于开放组(16.7% vs 6.5%,P=0.018)。
  • 围术期死亡仅开放组1例,两组早期死亡无显著差异(P=0.316)。

核心结论

  • 择期腹主动脉瘤治疗中开放修复与EVAR均可安全实施,远期生存相当,但EVAR再干预率显著更高。

研究设计与样本

  • 单中心数据库回顾性研究,纳入1998至2006年择期修复的肾下腹主动脉瘤患者。
  • 按年龄、性别、肾病、吸烟、高血压、慢阻肺和冠心病匹配EVAR与开放修复患者,最终每组各108例。

主要发现

  • 共识别465例择期肾下腹主动脉瘤修复患者,匹配后每组108例。
  • 早期死亡仅开放组1例(P=0.316)。
  • Kaplan-Meier生存分析经log-rank检验显示两组累积生存无差异(P=0.458)。

临床怎么用

  • EVAR与开放修复均可作为择期肾下腹主动脉瘤的治疗选择,选择时需权衡再干预风险。
  • EVAR术后应重视随访监测,以应对较高的再干预需求。

局限性

  • 为单中心回顾性研究,样本来自1998至2006年的数据库。
  • 匹配仅基于年龄、性别、肾病、吸烟、高血压、慢阻肺和冠心病等特征。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The purpose of the present study was to compare the long-term survival in matched cohorts of patients with infrarenal abdominal aortic aneurysm (AAA) undergoing an elective open repair (OR) or an endovascular aneurysm repair (EVAR). METHODS: Patients with a primary elective repair of an infrarenal aortic aneurysm between 1998 and 2006 were identified in a retrospective review of our single-center database. EVAR and OR patients were matched with respect to age, gender, renal disease, tobacco use, hypertension, chronic obstructive pulmonary disease, and coronary artery disease. The primary end points were the early mortality and all-cause mortality during follow-up. RESULTS: A total of 465 patients with elective infrarenal aortic aneurysm repair were identified in the database. The EVAR and OR patients were matched according to the above-mentioned characteristics, and finally, 108 patients were included in each group. The early mortality encountered was only one death in the open group (P = 0.316). The Kaplan-Meier survival analysis by the log-rank test showed no difference in cumulative survival between OR group and EVAR group (P = 0.458). Seventeen reinterventions (16.7%) in the EVAR group vs. 7 (6.5%) in the OR group (P = 0.018) were necessary during follow-up. CONCLUSIONS: OR and EVAR can be performed safely for elective treatment of AAA. The reintervention rate is, as expected, significantly higher in the EVAR group, but the long-term survival remains equal in both groups.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Majd P, Ahmad W, Becker I, et al. Ten-Year Single-Center Results of Abdominal Aortic Aneurysm Treatment: Endovascular versus Open Repair. Ann Vasc Surg. 2017. PMID: 28546041. doi:10.1016/j.avsg.2017.05.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。